Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

Summary

This study will describe the pharmacokinetic disposition of biologically active rabbit anti-thymocyte globulin (rATG) after a consistent dose of 7.5 mg/kg/course given as part of the conditioning regimen in children undergoing hematopoeitic stem cell transplantation (HSCT).

Timeline

Start

2009-11

Primary completion

2014-01

Completion

2014-01

Drugs

Indications